PCV-20
- Generic Name
- PCV-20
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan
Phase 3
Completed
- Conditions
- Pneumococcal Disease
- Interventions
- First Posted Date
- 2021-05-06
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1425
- Registration Number
- NCT04875533
- Locations
- 🇯🇵
Seishinkai Inoue Hospital, Itoshima, Fukuoka, Japan
🇯🇵Medical Corporation Heishinkai OPHAC Hospital, Osaka-shi, Osaka, Japan
🇯🇵Fukuwa Clinic, Chuo-ku, Tokyo, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath